Equities

Rossari Biotech Ltd

ROSSARI:NSI

Rossari Biotech Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)704.00
  • Today's Change4.80 / 0.69%
  • Shares traded14.55k
  • 1 Year change-4.72%
  • Beta0.8978
Data delayed at least 15 minutes, as of May 18 2024 08:13 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.

  • Revenue in INR (TTM)18.31bn
  • Net income in INR1.31bn
  • Incorporated2009
  • Employees500.00
  • Location
    Rossari Biotech LtdLbs Marg, Next To Ge Gardens, Kanjurmarg201-A & B, Ackruti Corporate ParkMUMBAI 400078IndiaIND
  • Phone+91 2 261233800
  • Fax+91 2 261233846
  • Websitehttps://www.rossari.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Thirumalai Chemicals Ltd20.83bn-387.90m27.08bn526.00--2.36110.921.30-3.79-3.79203.73111.900.73345.8414.61---1.375.26-2.057.5220.1226.26-1.865.640.8583-0.2920.52219.92-2.3010.56-143.18--33.22-12.94
India Pesticides Ltd7.52bn891.33m28.54bn280.0031.91--27.633.797.777.7765.60--------26,866,790.00--------41.48--11.85----24.73----23.57---9.32------
Sharda Cropchem Ltd31.63bn318.83m37.25bn182.00119.551.6612.461.183.453.45349.50247.960.75412.201.90--0.76076.801.3211.6825.9428.031.017.361.232.430.008119.39-21.819.59-90.68-28.9713.72-5.59
Neogen Chemicals Ltd6.91bn356.60m38.29bn581.00104.265.0465.425.5413.9213.92270.64288.190.54921.133.01--2.845.354.528.3444.6232.995.167.590.76142.080.349715.520.654423.64-28.6611.1371.955.92
Rossari Biotech Ltd18.31bn1.31bn38.63bn500.0029.603.6920.222.1123.6223.62330.69189.651.255.494.70--8.8910.5312.0614.3429.3429.847.147.661.329.860.10182.2610.5528.8121.8523.3924.44--
Fineotex Chemical Ltd5.54bn1.16bn39.89bn103.0034.51--32.737.2110.4410.4450.02--------53,751,720.00--17.65--21.9038.3335.2121.0515.49--136.92--8.2540.4029.3260.0731.2346.9631.95
Bharat Rasayan Ltd10.41bn586.50m40.52bn797.0069.09--47.923.89141.16141.162,505.13--------13,060,150.00--17.10--22.8828.4728.495.6312.57--28.84--0.4305-5.138.78-29.194.85-10.500.00
Nocil Ltd14.81bn1.20bn43.59bn675.0036.51--25.182.947.167.1688.59--------21,939,110.00--9.20--10.4343.1436.298.0912.15--99.39--38.642.8810.32-15.31-2.57-8.973.71
Privi Speciality Chemicals Ltd17.52bn949.07m44.58bn725.0046.724.8220.372.5424.4324.43447.68236.640.74031.575.45--4.035.097.038.5334.5030.725.456.480.53842.060.51726.148.985.49327.230.1404-2.31-4.36
AMI Organics Ltd7.17bn427.73m46.12bn602.0095.396.8471.536.4313.1113.11199.16182.750.77032.983.29--5.2310.476.9314.4742.6245.446.7911.761.1918.930.240911.7816.3325.14-48.6512.9267.37--
GHCL Ltd34.43bn7.94bn47.92bn3.84k6.011.615.351.3983.2683.26361.06311.150.77352.7817.29--17.8314.1819.6617.1842.6139.4323.0618.662.7328.150.065914.59-24.180.622-28.8517.76-17.7419.14
National Fertilizers Limited245.60bn-2.94bn49.92bn2.99k----76.440.2033-5.99-5.99501.09--------82,139,260.00--1.25--2.869.4816.40-1.200.884---2.37----86.7727.03582.4016.59-9.37--
Sudarshan Chemical Industries Ltd24.66bn3.32bn50.91bn1.03k15.44--10.882.0647.6347.63350.86--------24,032,330.00--6.44--11.5444.0233.5613.466.14--2.88--25.424.5911.23-65.55-10.2617.13-15.59
Data as of May 18 2024. Currency figures normalised to Rossari Biotech Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

15.28%Per cent of shares held by top holders
HolderShares% Held
SBI Funds Management Ltd.as of 30 Apr 20242.90m5.24%
UTI Asset Management Co. Ltd. (Investment Management)as of 30 Apr 20242.84m5.14%
Canara Robeco Asset Management Co. Ltd.as of 30 Apr 20241.07m1.93%
APG Asset Management NVas of 31 Dec 2022728.24k1.32%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 2024587.49k1.06%
Templeton Investment Counsel LLCas of 31 Mar 2024116.27k0.21%
BlackRock Advisors (UK) Ltd.as of 09 May 202474.13k0.13%
Dimensional Fund Advisors LPas of 09 May 202450.11k0.09%
BlackRock Fund Advisorsas of 09 May 202443.33k0.08%
Fiduciary Management, Inc.as of 29 Feb 202440.34k0.07%
More ▼
Data from 31 Mar 2024 - 15 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.